Company Overview and News
The Indian benchmark indices including the Sensex are trading mixed this Thursday morning with the Sensex trading higher by 12 points at 36,386 while the Nifty is trading lower by 20 points at 10,960.
IOC 500325 UBL JISLJALEQS 532712 ASIANPAINT 532478 RCOM 508814 534816 532480 500696 RLNIY ASHOKLEY SBAZ 500219 UNIPLY HTMEDIA ALBK 530965 530005 AKLD TATASTEEL TATLY 507458 523204 AKLS ANDHRABANK BHRYY 500820 RELIANCE 532418 HINDUNILVR BHRQY ABAN 532662 500470 532461 RIGD INFRATEL 500477 INDIACEM BHARTIARTL 570004 UBNC 517354 HVLQY HINDALCO UBHOLDINGS 532646 UNBWY 532454 HNDNF TTST PNJZY JISLDVREQS HAVELLS PNB COSMOFILMS 500440
NEW DELHI (Bloomberg) -- The U.S. embargo on Iran oil shipments has put Prime Minister Narendra Modi in a quandary. If he plays along, India could find itself on the right side of President Donald Trump on trade but lose cheap supplies and precious foreign exchange.
After starting the week on a negative note, the market on Tuesday looked to reclaim its positive momentum from last week, backed by sharp gains in midcaps. The Sensex managed to end the day almost 200 points higher, while the Nifty managed to end above 11,000-mark.
IOC 500469 532617 TCHQY HINDUNILVR FEDA 532755 532187 532461 FEDS 500696 500477 FEDERALBNK ASHOKLEY SBAZ INDIGO INDUSINDBK JETAIRWAYS FDBAY 530965 AKLD TECHM 539448 PNJZY PNB AKLS
The Indian benchmark indices including the Sensex continues to trade on a positive note this Tuesday afternoon with the index trading 124 points at 36,447 while the Nifty is trading higher by 56 points at 10,993.
500325 FEDA JISLJALEQS 532712 533137 533644 SYNDIBANK AMBUY FEDS 500696 LHFLY 500570 FEDERALBNK RLNIY ASHOKLEY 500219 EXIDEIND ANNRY APOLLOTYRE AYRQY YYBKY 530005 CNRYY EXQDY AXBA 532276 BATAINDIA CANBK 523204 ANDHRABANK 521248 500825 500425 532418 AMBUJACEM IDFCBANK AXISBANK RIGD KITEX TATAMOTORS HINDALCO 532648 532524 AXBKY HNDNF ICICIBANK 500043 500440 TTM IOC MUTHOOTFIN BRTQY 512599 539437 DEN RCOM 532483 532480 BRITANNIA 500493 500253 BHARATFORG GICHSGFIN 513691 RELCAPITAL AXB PTC ALBK FDBAY 530965 511676 AKLD TATASTEEL TATLY LICHSGFIN UJAAS 534809 PCJEWELLER AKLS ADANIENT 500469 RELIANCE HINDUNILVR 533398 532215 ABAN 500470 532461 500477 INDIACEM 500111 YESBANK 570004 UBNC 500877 IBN TTST PNJZY 532174 JISLDVREQS JMTAUTOLTD PNB 500086
The Indian benchmark indices including the Sensex continues to trade on a positive note this Tuesday afternoon with the index trading 48 points at 36,372 while the Nifty is trading higher by 27 points at 10,964.
500325 FEDA JISLJALEQS 532712 533137 533644 SYNDIBANK AMBUY FEDS 500696 LHFLY 500570 FEDERALBNK RLNIY ASHOKLEY 500219 EXIDEIND ANNRY APOLLOTYRE AYRQY YYBKY 530005 CNRYY EXQDY AXBA 532276 BATAINDIA CANBK 523204 ANDHRABANK 521248 500825 500425 532418 TTNQY AMBUJACEM 532540 IDFCBANK AXISBANK RIGD KITEX TV18BRDCST TATAMOTORS 532648 532800 532524 AXBKY ICICIBANK 500043 TTM IOC MUTHOOTFIN BRTQY 512599 539437 DEN RCOM 532483 532480 BRITANNIA 500493 500253 BHARATFORG GICHSGFIN RELCAPITAL AXB PTC ALBK FDBAY 530965 511676 AKLD TATASTEEL TATLY LICHSGFIN UJAAS TCS 534809 PCJEWELLER AKLS ADANIENT 500469 RELIANCE HINDUNILVR 533398 532215 ABAN 500470 532461 500477 INDIACEM 500111 YESBANK 570004 UBNC 500877 IBN TTST PNJZY 532174 JISLDVREQS PNB 500086
The Indian benchmark indices including the Sensex is trading on a positive note this Tuesday morning with the index trading 101 points at 36,424 while the Nifty is trading higher by 41 points at 10,978.
IOC 500325 500008 BRTQY FEDA 532636 IIFL 532712 ARJQY 533137 539437 DEN 533644 RCOM 532483 AMBUY FEDS 500696 GAILF BRITANNIA FEDERALBNK SUNTV RLNIY ASHOKLEY GICHSGFIN EXIDEIND AXB RMCTY PTC FDBAY YYBKY 530965 511676 530005 AKLD CNRYY 500260 AXBA EXQDY TATASTEEL TATLY UJAAS GAILY 532391 534809 TCS PCJEWELLER CANBK AKLS ANDHRABANK 521248 500825 OPTOCIRCUI 500425 500469 RELIANCE 532418 HINDUNILVR TTNQY 532733 AMBUJACEM 532215 AMARAJABAT 500470 532540 IDFCBANK 532461 AXISBANK RIGD RADICO KITEX 500477 INDIACEM TV18BRDCST YESBANK IBN 532648 532800 532524 AXBKY 532497 ICICIBANK TTST PNJZY 532174 RAMCOCEM PNB SNQVY 500086
Mumbai: With natural gas prices shooting up globally, Essar Ports is going slow on its plans to build liquefied natural gas terminals at the Hazira port in Gujarat, chief executive officer Rajiv Agarwal told Mint.
IOC PQRTY 530965 PETRONET 532522
New Delhi:Fitch Ratings on Monday said it expects state-owned Indian Oil Corp’s (IOC’s) net debt levels to increase due to its large capital expenditure and investment plans in the medium term and affirmed a rating equivalent to India’s sovereign rating.
Fitch Ratings today it expects state-owned Indian Oil Corp's (IOC) net debt levels to increase due to its large capital expenditure and investment plans in the medium term and affirmed a rating equivalent to India's sovereign rating.
New Delhi: Petrol prices fell around 10 paise across the four metro cities on Monday after rising nearly a rupee and a half in the last 10 days. Prices of diesel also were down around 13-15 paise from the levels on Sunday.
HOUSTON/NEW DELHI, July 12 (Reuters) - U.S. crude oil exports to India hit a record in June and so far this year are almost double last year’s total as the Asian nation’s refiners move to replace supplies from Iran and Venezuela in a win for the Trump administration.
IOC 500325 RELIANCE RIGD 530965 RLNIY
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...